BIOMICTRA®
Recurrent Clostridioides difficile infection
MarketedActive
Key Facts
About BiomeBank
Australian biotech leveraging co‑cultured gut microbiome consortia to deliver regulated, scalable therapies for C. and and ulcerative colitis.
View full company profile